Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Foundation Fighting Blindness Stories

2012-07-22 22:20:39

OXFORD, England, July 23, 2012 /PRNewswire/ -- -- Award of US$125,000 will support a second clinical site in Paris, France -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US non-profit organisation, the Foundation Fighting Blindness (FFB), has granted an award of US$125,000 to the Company via its translational research arm, the Foundation Fighting Blindness Clinical...

2012-05-17 10:26:04

CLEVELAND, May 17, 2012 /PRNewswire/ -- On May 19th, thousands will join forces to raise awareness for those affected by retinal degenerative diseases. Money raised through VisionWalk supports the important research funded by the Foundation Fighting Blindness, a national 501(c)(3) organization. The walk is at Wade Oval, and thousands of family members of those affected by retinal degenerative diseases will show support. Registration is at 9a, and the Walk begins at 10a. One of the...

2012-01-23 22:46:02

A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both youngsters and adults. The technique works by replacing a malfunctioning gene in the eye with a normal working copy that supplies a protein necessary for light-sensitive cells in the eye to function. The findings are published today (Monday, Jan. 23) in the Proceedings of the National Academy of Sciences online. Several complex and costly steps...

2011-10-18 01:00:00

OXFORD, England, October 18, 2011 /PRNewswire/ -- -- Third ocular product partnered with Sanofi approved to enter clinical development -- Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat(R), a novel gene-based treatment for Usher...

2011-06-22 01:00:00

OXFORD, England, June 22, 2011 /PRNewswire/ -- - RetinoStat(R) Progress in Phase I Study in Wet Age-Related Macular Degeneration Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, today announces that the first dose level of RetinoStat(R) is safe and well-tolerated at one month following treatment. RetinoStat(R) is a novel gene-based treatment for neovascular "wet" age-related macular degeneration (AMD), designed and...

216f1e2c8e43683d7c2bda043fb9a614
2011-06-17 12:40:00

The first two patients with common but incurable diseases of the eye that can lead to blindness have been enrolled early in a two phase groundbreaking clinical trial of therapy that researchers are hoping will heal the damage caused by the conditions. Advanced Cell Technology Inc. (ACT) announced Thursday the enrollment of the patients in the trials for Stargardt's Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (Dry AMD). The patients were enrolled at the Jules Stein Eye...

2011-06-16 00:00:30

The Foundation Fighting Blindness, a national nonprofit that drives eyesight-saving research, will honor Ophthalmologist and Virginia Eye Institute Founder Anthony D. Sakowski, Jr., M.D., F.A.C.S., at the Richmond Dining in the Dark event. The unique luncheon will take place at noon on June 16 at the Richmond Marriott. Richmond, VA (PRWEB) June 15, 2011 The Foundation Fighting Blindness, a national nonprofit that drives eyesight-saving research, will honor Ophthalmologist and Virginia Eye...

2011-06-10 00:00:30

The Foundation Fighting Blindness held its 6th annual Vision Walk which took place at Browns Chapel Park in Reston Virginia on Saturday, May 7th. Owner of McGrath Real Estate, Tim McGrath, supported "ËœJo's Vision Walker's' which is one of the teams of the Northern Virginia chapter headed by Dale and Jo Adams. Herndon, VA (PRWEB) June 09, 2011 McGrath Real Estate has been working in the Northern Virginia Real Estate market since 1976. While working to serve the real estate...

2011-05-18 14:21:34

Lab Study Shows an Improved Form of Vitamin A May Help Slowing down the aggregation or "clumping" of vitamin A in the eye may help prevent vision loss caused by macular degeneration, research from Columbia University Medical Center has found. Rather than changing the way the eye processes vitamin A, a team of researchers led by Ilyas Washington, a professor in the department of ophthalmology at Columbia's Harkness Eye Institute, decided to focus on changing the structure of vitamin A itself....

2010-08-05 13:56:27

Neurobiologists funded by the Office of Naval Research (ONR) have discovered a potential cure for degenerative vision diseases leading to terminal blindness. The solution, however, may be rooted in an unconventional therapeutic approach. Scientists at the Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland, are manipulating the proteins that cause blindness in mice. The scientists have successfully restored vision in the light-sensing cells of the retina. Dr. Thomas...